Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cognitive Dysfunction × Tablets × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Diabetes Mellitus 2 Vomiting 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Premature Birth 1 Pre-Eclampsia 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Neoplasms 1 Medulloblastoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Leiomyosarcoma 1 Hyperparathyroidism, Primary 1 Hot Flashes 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Erectile Dysfunction 1 Cognitive Dysfunction 1 Carcinoma, Renal Cell 1

Interventions

mazdutide 1 Tablets 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Metformin 1 Memantine 1 Hormones 1 G(M1) Ganglioside 1 Exercise 1 Donepezil 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡